American University of Beirut

Skip Navigation LinksHome > Faculty of Medicine > Calcium Metabolism and Osteoporosis Program > Research Projects

Research Projects

​​​​​​​​​​​​​​​Ongoing Clinical Trials

Other Ongoing Projects, Systematic Reviews, and Meta-analyses

  • SNPs Vitamin D Metabolic Pathway and Predictors of Vitamin D levels before and after Intervention in the Lebanese.
    Dania El-Bacha, Marlene Chakhtoura, George Nemer, Pierre Khoueiry, Ghada El-Hajj Fuleihan.
  • Rate of drop in serum calcium as a predictor of hypo-calcemic symptoms post total thyroidectomy.
    Randa Saad, Nathalie Boueiz, Vanessa Akiki, Ghada El-Hajj Fuleihan.
  • Vitamin D and bone-fat cross talk.
    Aya Bassatne, Ghada El-Hajj Fuleihan.
  • Osteoporosis disease burden and other NCDs in Lebanon.
    Aya Bassatne, Ghada El-Hajj Fuleihan.

​​Completed Clinical Trials

  • Level and predictors of vitamin D deficiency in a large data set. 
    Randa Saad, Vanessa Akiki, Maya Rahme, Sara Ajjour, Mariam Assaad, Ghada El-Hajj Fuleihan.

  • ​​Secular trends and care gap in hip fracture patients in Lebanon. 
    Randa Saad, Hilda Harb, Walid Ammar, Ibrahim Bou Orm, Ghada El-Hajj Fuleihan.

  • ​Secular trends in vitamin D levels in an Institutional laboratory database.
    Randa Saad, Vanessa Akiki, Maya Rahme, Sara Ajjour, Mariam Assaad, Ruba Riachy, Ghada El-Hajj Fuleihan.

  • Vitamin D metabolites as predictors of bone metabolic parameters before and after s​upplementation in the elderly: A Randomized Control Trial. 
    Paola Ghanem, Malak El Sabeh, Ghada El-Hajj Fuleihan.

  • “Hypovitaminosis D: A Link between Bone and Fat Fuel Metabolism”. Funded by AUB, USJ and LCNRS. NCT01315366; clinicaltrials.gov. 2011-2015.

    Principle Investigator: Ghada El-Hajj Fuleihan, MD, MPH. 
    Co-investigators: 
    AUB: Asma Arabi, Robert Habib
    HDDF: Rafic Baddoura and Georges Halabi
    RHUH: Samer Kabbani, Wissam Nasreddine, Mohammad Rawwas

  • CYP2R1 Polymorphisms as Modulators of Circulating 25-Hydroxyvitamin D Levels and of Response to Treatment with Vitamin D. AUB. 2012-2014.

    ​Principle Investigator: Asma Arabi, MD, MSc. 
    Co-investigators: Ghada El-Hajj Fuleihan, MD, MPH, Nathalie Zgheib, Rami Mahfoud

  • The Effect of Vitamin D, Atorvastatin, and Fluvastatin on Cardiovascular Disease Risk Factors In Women with Polycystic Ovary Syndrome: A Prospective Randomized Controlled Parallel Three Arm Trial. 2012-2014.

    Principle Investigator: Ghina Ghazeeri
    Co-investigators: Anwar Nassar, Ghada El-Hajj Fuleihan, Johny Awwad

  • Vitamin D Status in Mothers and Their Newborns in Lebanon and its Impact on Labor and Neonatal Outcome: A Prospective Cohort Study. 2012-2014.

    Principle Investigator: Fadi Mirza
    Co-investigators: Ghada El-Hajj Fuleihan, Anwar Nassar, Ghina Ghazeeri​
  • Phase III (Phase V program), Open-label-Randomized, Referred-Care-Control Clinical Trial to Evaluate the Efficacy and Safety of MK-0217A/Alendronate Sodium 70 mg/Vitamin D3 5600 IU Combination Tablet on Vitamin D Inadequacy in the Treatment of Osteoporosis in Postmenopausal Women. Merck Sharp & Dohme. 2008-2010. 

    ​Principal Investigator: Asma Arabi, MD, MSc
    ​​Co-investigators: Elie El Haj

  • A multicenter, double –blind, randomized, active controlled, parallel group, non-inferiority study comparing 75 mg Risedronate dosed on two consecutive days monthly with 5 mg daily Risedronate in the treatment of postmenopausal osteoporosis as assessed over 24 months. Aventis. 2005-2007.

    Principle Investigator: Ghada El-Hajj Fuleihan, MD, MPH.
    Co-investigators: Asma Arabi, Joyce Maalouf.

  • Effect of vitamin D replacement on musculoskeletal parameters in healthy school children: a randomized controlled trial. J Clin Endocrinol Metab 2006;91:405-412.

    Principle Investigator: Ghada El-Hajj Fuleihan, MD, MPH.
    Co-investigators: Mona Nabulsi, Joyce Maalouf, Asma Arabi.

  • A randomized, double blind, placebo-controlled, parallel group, multicenter, two years phase III study to determine the efficacy and safety of Risedronate therapy administered 35 mg once a week in Men with osteoporosis. MASTER trial Aventis/ Procter and Gamble. 2003-2006.

    Principle Investigator: Ghada El-Hajj Fuleihan, MD, MPH.
    Co-investigators: Asma Arabi, Joyce Maalouf.

  • Effect of Vitamin D Replacement on Musculoskeletal Parameters in School Children: A Randomized Controlled Trial. Merck Sharp & Dohme. 2001-2002.

    Principal Investigator: Ghada El-Hajj Fuleihan, MD, MPH.
    Co-investigators: Mona Nabulsi, Hala Tamim, Joyce Maalouf, Mariana Salamoun, Hassan Khalife, Mahmoud Choucair, Asma Arabi, and Reinhold Vieth.



 Related Links

​​Research Publications​

Contact Us

For various questions, please try contacting us via social media first!
read more

Privacy Statement

We take data privacy seriously and adhere to all applicable data privacy laws and regulations.
read more

Copyright and Disclaimer

Written permission is needed to copy or disseminate all or part of the materials on the AUB website.
read more

Title IX, Non-Discrimination, and Anti-Discriminatory Harassment

AUB is committed to providing a safe, respectful, and inclusive environment to all members of its community.
read more